Ke Xu
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Circular RNAs in diseases 8
-
- MicroRNA in disease regulation 18
- Cancer-related molecular mechanisms research 13
- Cancer, Hypoxia, and Metabolism 8
- Co-authors
- Peihao Yin (27 shared papers)Xin Liang (15 shared papers)Lei Yu (1 shared paper)Jiacan Su (23 shared papers)Yanyan Qiu (14 shared papers)Jianwen Liu (9 shared papers)Zeting Yuan (11 shared papers)Xiang Wu (5 shared papers)
- Journals
- Oncotarget (6 papers)Cell Proliferation (4 papers)Blood (3 papers)Oncology Reports (3 papers)International Journal of Nanomedicine (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ke Xu
141 papers receiving 4.5k citations
Ke Xu's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 1.0k
- Oncology 727
- Molecular Biology 2.0k
- Immunology 412
- Biomaterials 260
Countries citing papers authored by Ke Xu
This map shows the geographic impact of Ke Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Xu more than expected).
Fields of papers citing papers by Ke Xu
This network shows the impact of papers produced by Ke Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Xu. The network helps show where Ke Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 252 | |
| 2 | 2017 | 171 | |
| 3 | 2012 | 163 | |
| 4 | Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases Hit paper breakdown → | 2023 | 143 |
| 5 | 2019 | 135 | |
| 6 | 2020 | 121 | |
| 7 | Boosting cartilage repair with silk fibroin-DNA hydrogel-based cartilage organoid precursor Hit paper breakdown → | 2024 | 115 |
| 8 | 2021 | 112 | |
| 9 | 2017 | 110 | |
| 10 | 2011 | 95 | |
| 11 | 2019 | 94 | |
| 12 | 2012 | 83 | |
| 13 | 2021 | 82 | |
| 14 | 2022 | 78 | |
| 15 | A Factor‐Free Hydrogel with ROS Scavenging and Responsive Degradation for Enhanced Diabetic Bone Healing Hit paper breakdown → | 2024 | 77 |
| 16 | 2012 | 67 | |
| 17 | 2022 | 66 | |
| 18 | 2010 | 64 | |
| 19 | 2016 | 63 | |
| 20 | 2020 | 62 |
About Ke Xu
Ke Xu is a scholar working on Molecular Biology, Cancer Research, Oncology, Biomedical Engineering and Immunology, having authored 147 papers that have together received 4.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (13 papers), Cancer Cells and Metastasis (11 papers), Osteoarthritis Treatment and Mechanisms (8 papers), Cytokine Signaling Pathways and Interactions (8 papers), Cancer, Hypoxia, and Metabolism (8 papers), Circular RNAs in diseases (8 papers) and Nanoplatforms for cancer theranostics (8 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (727 citations), Molecular Biology (2.0k citations), Immunology (412 citations) and Biomaterials (260 citations). Ke Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Peihao Yin, Xin Liang, Lei Yu, Jiacan Su, Yanyan Qiu, Jianwen Liu, Zeting Yuan, Xiang Wu, Boning Liu and Yueping Zhan. Their work appears in journals such as Oncotarget, Cell Proliferation, Blood, Oncology Reports and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.